Sign in to edit your profile (add interests, mentoring, photo, etc.)
    Keywords
    Last Name
    Institution

    James Kahn, MD, MPH

    TitleProfessor in Residence
    SchoolUCSF School of Medicine
    DepartmentInstitute for Health Policy Studies
    Address3333 Calif. St,Laurel Heights
    San Francisco CA 94143
    Phone415-476-6642

       Bibliographic 
       Publications
      Publications by year:
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      1. Sutherland T, Downing J, Miller S, Bishai DM, Butrick E, Fathalla MM, Mourad-Youssif M, Ojengbede O, Nsima D, Kahn JG. Use of the Non-Pneumatic Anti-Shock Garment (NASG) for Life-Threatening Obstetric Hemorrhage: A Cost-Effectiveness Analysis in Egypt and Nigeria. PLoS One. 2013; 8(4):e62282.
        View in: PubMed
      2. Audureau E, Kahn JG, Besson MH, Saba J, Ladner J. Scaling up prevention of mother-to-child HIV transmission programs in sub-Saharan African countries: a multilevel assessment of site-, program- and country-level determinants of performance. BMC Public Health. 2013; 13:286.
        View in: PubMed
      3. Marseille E, Lohse N, Jiwani A, Hod M, Seshiah V, Yajnik CS, Arora GP, Balaji V, Henriksen O, Lieberman N, Chen R, Damm P, Metzger BE, Kahn JG. The cost-effectiveness of gestational diabetes screening including prevention of type 2 diabetes: application of a new model in India and Israel. J Matern Fetal Neonatal Med. 2013 May; 26(8):802-10.
        View in: PubMed
      4. Marseille E, Giganti MJ, Mwango A, Chisembele-Taylor A, Mulenga L, Over M, Kahn JG, Stringer JS. Taking ART to Scale: Determinants of the Cost and Cost-Effectiveness of Antiretroviral Therapy in 45 Clinical Sites in Zambia. PLoS One. 2012; 7(12):e51993.
        View in: PubMed
      5. Abeyasinghe RR, Galappaththy GN, Smith Gueye C, Kahn JG, Feachem RG. Malaria control and elimination in Sri Lanka: documenting progress and success factors in a conflict setting. PLoS One. 2012; 7(8):e43162.
        View in: PubMed
      6. Granich R, Kahn JG, Bennett R, Holmes CB, Garg N, Serenata C, Sabin ML, Makhlouf-Obermeyer C, De Filippo Mack C, Williams P, Jones L, Smyth C, Kutch KA, Ying-Ru L, Vitoria M, Souteyrand Y, Crowley S, Korenromp EL, Williams BG. Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050. PLoS One. 2012; 7(2):e30216.
        View in: PubMed
      7. Kahn JG, Muraguri N, Harris B, Lugada E, Clasen T, Grabowsky M, Mermin J, Shariff S. Integrated HIV testing, malaria, and diarrhea prevention campaign in Kenya: modeled health impact and cost-effectiveness. PLoS One. 2012; 7(2):e31316.
        View in: PubMed
      8. Marseille EA, Kevany S, Ahmed I, Feleke G, Graham B, Heller T, Kahn JG, Reyes M. Case management to improve adherence for HIV-infected patients receiving antiretroviral therapy in Ethiopia: a micro-costing study. Cost Eff Resour Alloc. 2011; 9:18.
        View in: PubMed
      9. Kahn JG, Marseille E, Moore D, Bunnell R, Were W, Degerman R, Tappero JW, Ekwaru P, Kaharuza F, Mermin J. CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study. BMJ. 2011; 343:d6884.
        View in: PubMed
      10. Lohse N, Marseille E, Kahn JG. Development of a model to assess the cost-effectiveness of gestational diabetes mellitus screening and lifestyle change for the prevention of type 2 diabetes mellitus. Int J Gynaecol Obstet. 2011 Nov; 115 Suppl 1:S20-5.
        View in: PubMed
      11. Bozic KJ, Chiu V, Slover JD, Immerman I, Kahn JG. Patient preferences and willingness to pay for arthroplasty surgery in patients with osteoarthritis of the hip. J Arthroplasty. 2012 Apr; 27(4):503-506.e2.
        View in: PubMed
      12. Tatarsky A, Aboobakar S, Cohen JM, Gopee N, Bheecarry A, Moonasar D, Phillips AA, Kahn JG, Moonen B, Smith DL, Sabot O. Preventing the reintroduction of malaria in Mauritius: a programmatic and financial assessment. PLoS One. 2011; 6(9):e23832.
        View in: PubMed
      13. Kahn JG, Marseille EA, Bennett R, Williams BG, Granich R. Cost-effectiveness of antiretroviral therapy for prevention. Curr HIV Res. 2011 Sep; 9(6):405-15.
        View in: PubMed
      14. Jones L, Akugizibwe P, Clayton M, Amon JJ, Sabin ML, Bennett R, Stegling C, Baggaley R, Kahn JG, Holmes CB, Garg N, Obermeyer CM, Mack CD, Williams P, Smyth C, Vitoria M, Crowley S, Williams B, McClure C, Granich R, Hirnschall G. Costing human rights and community support interventions as a part of universal access to HIV treatment and care in a Southern African setting. Curr HIV Res. 2011 Sep; 9(6):416-28.
        View in: PubMed
      15. Granich R, Lo YR, Suthar AB, Vitoria M, Baggaley R, Obermeyer CM, McClure C, Souteyrand Y, Perriens J, Kahn JG, Bennett R, Smyth C, Williams B, Montaner J, Hirnschall G. Harnessing the prevention benefits of antiretroviral therapy to address HIV and tuberculosis. Curr HIV Res. 2011 Sep; 9(6):355-66.
        View in: PubMed
      16. Jiwani A, Marseille E, Lohse N, Damm P, Hod M, Kahn JG. Gestational diabetes mellitus: results from a survey of country prevalence and practices. J Matern Fetal Neonatal Med. 2012 Jun; 25(6):600-10.
        View in: PubMed
      17. De Ver Dye T, Apondi R, Lugada E, Kahn JG, Sandiford-Day MA, Dasbanerjee T. A qualitative assessment of beliefs, attitudes, and behaviors related to diarrhea and water filtration in rural Kenya. Am J Public Health. 2011 Aug; 101(8):1515-20.
        View in: PubMed
      18. Bozic KJ, Chiu VW, Slover JD, Immerman I, Kahn JG. Health state utility in patients with osteoarthritis of the hip and total hip arthroplasty. J Arthroplasty. 2011 Sep; 26(6 Suppl):129-132.e1-2.
        View in: PubMed
      19. Dye TD, Apondi R, Lugada ES, Kahn JG, Smith J, Othoro C. "Before we used to get sick all the time": perceptions of malaria and use of long-lasting insecticide-treated bed nets (LLINs) in a rural Kenyan community. Malar J. 2010; 9:345.
        View in: PubMed
      20. Sabot O, Cohen JM, Hsiang MS, Kahn JG, Basu S, Tang L, Zheng B, Gao Q, Zou L, Tatarsky A, Aboobakar S, Usas J, Barrett S, Cohen JL, Jamison DT, Feachem RG. Costs and financial feasibility of malaria elimination. Lancet. 2010 Nov 6; 376(9752):1604-15.
        View in: PubMed
      21. Lugada E, Millar D, Haskew J, Grabowsky M, Garg N, Vestergaard M, Kahn JG, Khan JG, Kahn J, Muraguri N, Mermin J. Rapid implementation of an integrated large-scale HIV counseling and testing, malaria, and diarrhea prevention campaign in rural Kenya. PLoS One. 2010; 5(8):e12435.
        View in: PubMed
      22. Granich R, Crowley S, Vitoria M, Smyth C, Kahn JG, Bennett R, Lo YR, Souteyrand Y, Williams B. Highly active antiretroviral treatment as prevention of HIV transmission: review of scientific evidence and update. Curr Opin HIV AIDS. 2010 Jul; 5(4):298-304.
        View in: PubMed
      23. Kahn JG, Yang JS, Kahn JS. 'Mobile' health needs and opportunities in developing countries. Health Aff (Millwood). 2010 Feb; 29(2):252-8.
        View in: PubMed
      24. Doyle SM, Kahn JG, Hosang N, Carroll PR. The impact of male circumcision on HIV transmission. J Urol. 2010 Jan; 183(1):21-6.
        View in: PubMed
      25. Burgos JL, Kahn JG, Strathdee SA, Valencia-Mendoza A, Bautista-Arredondo S, Laniado-Laborin R, Castañeda R, Deiss R, Garfein RS. Targeted screening and treatment for latent tuberculosis infection using QuantiFERON-TB Gold is cost-effective in Mexico. Int J Tuberc Lung Dis. 2009 Aug; 13(8):962-8.
        View in: PubMed
      26. Sakowski JA, Kahn JG, Kronick RG, Newman JM, Luft HS. Peering into the black box: billing and insurance activities in a medical group. Health Aff (Millwood). 2009 Jul-Aug; 28(4):w544-54.
        View in: PubMed
      27. Marseille E, Kahn JG, Pitter C, Bunnell R, Epalatai W, Jawe E, Were W, Mermin J. The cost effectiveness of home-based provision of antiretroviral therapy in rural Uganda. Appl Health Econ Health Policy. 2009; 7(4):229-43.
        View in: PubMed
      28. Auvert B, Marseille E, Korenromp EL, Lloyd-Smith J, Sitta R, Taljaard D, Pretorius C, Williams B, Kahn JG. Estimating the resources needed and savings anticipated from roll-out of adult male circumcision in Sub-Saharan Africa. PLoS One. 2008; 3(8):e2679.
        View in: PubMed
      29. Kürzinger ML, Pagnier J, Kahn JG, Hampshire R, Wakabi T, Dye TD. Education status among orphans and non-orphans in communities affected by AIDS in Tanzania and Burkina Faso. AIDS Care. 2008 Jul; 20(6):726-32.
        View in: PubMed
      30. Dandona L, Kumar SP, Ramesh Y, Rao MC, Kumar AA, Marseille E, Kahn JG, Dandona R. Changing cost of HIV interventions in the context of scaling-up in India. AIDS. 2008 Jul; 22 Suppl 1:S43-9.
        View in: PubMed
      31. Potts M, Halperin DT, Kirby D, Swidler A, Marseille E, Klausner JD, Hearst N, Wamai RG, Kahn JG, Walsh J. Public health. Reassessing HIV prevention. Science. 2008 May 9; 320(5877):749-50.
        View in: PubMed
      32. Dandona L, Kumar SG, Ramesh YK, Rao MC, Marseille E, Kahn JG, Dandona R. Outputs, cost and efficiency of public sector centres for prevention of mother to child transmission of HIV in Andhra Pradesh, India. BMC Health Serv Res. 2008; 8:26.
        View in: PubMed
      33. Marseille E, Dandona L, Marshall N, Gaist P, Bautista-Arredondo S, Rollins B, Bertozzi SM, Coovadia J, Saba J, Lioznov D, Du Plessis JA, Krupitsky E, Stanley N, Over M, Peryshkina A, Kumar SG, Muyingo S, Pitter C, Lundberg M, Kahn JG. HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries. BMC Health Serv Res. 2007; 7:108.
        View in: PubMed
      34. Pitter C, Kahn JG, Marseille E, Lule JR, McFarland DA, Ekwaru JP, Bunnell R, Coutinho A, Mermin J. Cost-effectiveness of cotrimoxazole prophylaxis among persons with HIV in Uganda. J Acquir Immune Defic Syndr. 2007 Mar 1; 44(3):336-43.
        View in: PubMed
      35. Kahn JG, Marseille E, Auvert B. Cost-effectiveness of male circumcision for HIV prevention in a South African setting. PLoS Med. 2006 Dec; 3(12):e517.
        View in: PubMed
      36. Gardner A, Kahn JG. Increasing access to care for the uninsured: considering the options in California counties. J Health Care Poor Underserved. 2006 Nov; 17(4):830-50.
        View in: PubMed
      37. Shrestha RK, Marseille E, Kahn JG, Lule JR, Pitter C, Blandford JM, Bunnell R, Coutinho A, Kizito F, Quick R, Mermin J. Cost-effectiveness of home-based chlorination and safe water storage in reducing diarrhea among HIV-affected households in rural Uganda. Am J Trop Med Hyg. 2006 May; 74(5):884-90.
        View in: PubMed
      38. Marseille E, Saba J, Muyingo S, Kahn JG. The costs and benefits of private sector provision of treatment to HIV-infected employees in Kampala, Uganda. AIDS. 2006 Apr 4; 20(6):907-14.
        View in: PubMed
      39. Bozic KJ, Morshed S, Silverstein MD, Rubash HE, Kahn JG. Use of cost-effectiveness analysis to evaluate new technologies in orthopaedics. The case of alternative bearing surfaces in total hip arthroplasty. J Bone Joint Surg Am. 2006 Apr; 88(4):706-14.
        View in: PubMed
      40. Ikard K, Janney J, Hsu LC, Isenberg DJ, Scalco MB, Schwarcz S, Beer L, Wendell DA, Franks PE, Kahn JG. Estimation of unmet need for HIV primary medical care: a framework and three case studies. AIDS Educ Prev. 2005 Dec; 17(6 Suppl B):26-38.
        View in: PubMed
      41. McConnel CE, Stanley N, du Plessis JA, Pitter CS, Abdulla F, Coovadia HM, Marseille E, Kahn JG. The cost of a rapid-test VCT clinic in South Africa. S Afr Med J. 2005 Dec; 95(12):968-71.
        View in: PubMed
      42. Dandona L, Sisodia P, Prasad TL, Marseille E, Chalapathi Rao M, Kumar AA, Kumar SG, Ramesh YK, Over M, Someshwar M, Kahn JG. Cost and efficiency of public sector sexually transmitted infection clinics in Andhra Pradesh, India. BMC Health Serv Res. 2005; 5:69.
        View in: PubMed
      43. Kahn JG, Kronick R, Kreger M, Gans DN. The cost of health insurance administration in California: estimates for insurers, physicians, and hospitals. Health Aff (Millwood). 2005 Nov-Dec; 24(6):1629-39.
        View in: PubMed
      44. Dandona L, Sisodia P, Kumar SG, Ramesh YK, Kumar AA, Rao MC, Marseille E, Someshwar M, Marshall N, Kahn JG. HIV prevention programmes for female sex workers in Andhra Pradesh, India: outputs, cost and efficiency. BMC Public Health. 2005; 5:98.
        View in: PubMed
      45. Buchmueller TC, Grumbach K, Kronick R, Kahn JG. The effect of health insurance on medical care utilization and implications for insurance expansion: a review of the literature. Med Care Res Rev. 2005 Feb; 62(1):3-30.
        View in: PubMed
      46. Dandona L, Sisodia P, Ramesh YK, Kumar SG, Kumar AA, Rao MC, Someshwar M, Hansl B, Marshall N, Marseille E, Kahn JG. Cost and efficiency of HIV voluntary counselling and testing centres in Andhra Pradesh, India. Natl Med J India. 2005 Jan-Feb; 18(1):26-31.
        View in: PubMed
      47. Marseille E, Dandona L, Saba J, McConnel C, Rollins B, Gaist P, Lundberg M, Over M, Bertozzi S, Kahn JG. Assessing the efficiency of HIV prevention around the world: methods of the PANCEA project. Health Serv Res. 2004 Dec; 39(6 Pt 2):1993-2012.
        View in: PubMed
      48. Wilson AR, Kahn JG. Preventing HIV in injection drug users: choosing the best mix of interventions for the population. J Urban Health. 2003 Sep; 80(3):465-81.
        View in: PubMed
      49. Bitton A, Kahn JG. MSJAMA: Government share of health care expenditures. JAMA. 2003 Mar 5; 289(9):1165.
        View in: PubMed
      50. Gibson DR, Brand R, Anderson K, Kahn JG, Perales D, Guydish J. Two- to sixfold decreased odds of HIV risk behavior associated with use of syringe exchange. J Acquir Immune Defic Syndr. 2002 Oct 1; 31(2):237-42.
        View in: PubMed
      51. Marseille E, Hofmann PB, Kahn JG. HIV prevention before HAART in sub-Saharan Africa. Lancet. 2002 May 25; 359(9320):1851-6.
        View in: PubMed
      52. Palacio H, Kahn JG, Richards TA, Morin SF. Effect of race and/or ethnicity in use of antiretrovirals and prophylaxis for opportunistic infection: a review of the literature. Public Health Rep. 2002 May-Jun; 117(3):233-51; discussion 231-2.
        View in: PubMed
      53. Kahn JG, Zhang X, Cross LT, Palacio H, Birkhead GS, Morin SF. Access to and use of HIV antiretroviral therapy: variation by race/ethnicity in two public insurance programs in the U.S. Public Health Rep. 2002 May-Jun; 117(3):252-62; discussion 231-2.
        View in: PubMed
      54. Morin SF, Sengupta S, Cozen M, Richards TA, Shriver MD, Palacio H, Kahn JG. Responding to racial and ethnic disparities in use of HIV drugs: analysis of state policies. Public Health Rep. 2002 May-Jun; 117(3):263-72; discussion 231-2.
        View in: PubMed
      55. Kahn JG, Marseille E. A saga in international HIV policy modeling: preventing mother-to-child HIV transmission. J Policy Anal Manage. 2002; 21(3):499-505.
        View in: PubMed
      56. Heumann KS, Marx R, Lawrence SJ, Stump DL, Carroll DP, Hirozawa AM, Katz MH, Kahn JG. Cost-effectiveness of prevention referrals for high-risk HIV-negatives in San Francisco. AIDS Care. 2001 Oct; 13(5):637-42.
        View in: PubMed
      57. Kahn JG, Haile B, Kates J, Chang S. Health and federal budgetary effects of increasing access to antiretroviral medications for HIV by expanding Medicaid. Am J Public Health. 2001 Sep; 91(9):1464-73.
        View in: PubMed
      58. Kahn JG, Kegeles SM, Hays R, Beltzer N. Cost-effectiveness of the Mpowerment Project, a community-level intervention for young gay men. J Acquir Immune Defic Syndr. 2001 Aug 15; 27(5):482-91.
        View in: PubMed
      59. Eichner J, Kahn JG. Coordination of health coverage for Medicare enrollees: living with HIV/AIDS in California. Medicare Brief. 2001 Aug; (8):1-10.
        View in: PubMed
      60. Kahn JG. Expenditures for the care of patients with HIV. N Engl J Med. 2001 Jun 21; 344(25):1948-9.
        View in: PubMed
      61. Marseille E, Kahn JG, Billinghurst K, Saba J. Cost-effectiveness of the female condom in preventing HIV and STDs in commercial sex workers in rural South Africa. Soc Sci Med. 2001 Jan; 52(1):135-48.
        View in: PubMed
      62. Kahn JG, Marseille E. Fighting global AIDS: the value of cost-effectiveness analysis. AIDS. 2000 Nov 10; 14(16):2609-10.
        View in: PubMed
      63. Marseille E, Kahn JG, Mmiro F, Guay L, Musoke P, Fowler MG, Jackson JB. The cost effectiveness of a single-dose nevirapine regimen to mother and infant to reduce vertical HIV-1 transmission in sub-Saharan Africa. Ann N Y Acad Sci. 2000 Nov; 918:53-6.
        View in: PubMed
      64. Pinkerton SD, Holtgrave DR, Kahn JG. Is post-exposure prophylaxis affordable? AIDS. 2000 Feb 18; 14(3):325.
        View in: PubMed
      65. Kahn JG, Becker BJ, MacIsaa L, Amory JK, Neuhaus J, Olkin I, Creinin MD. The efficacy of medical abortion: a meta-analysis. Contraception. 2000 Jan; 61(1):29-40.
        View in: PubMed
      66. Marseille E, Kahn JG, Mmiro F, Guay L, Musoke P, Fowler MG, Jackson JB. Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa. Lancet. 1999 Sep 4; 354(9181):803-9.
        View in: PubMed
      67. Johnston SC, Gress DR, Kahn JG. Which unruptured cerebral aneurysms should be treated? A cost-utility analysis. Neurology. 1999 Jun 10; 52(9):1806-15.
        View in: PubMed
      68. Kahn JG, Pinkerton SD, Paltiel AD. Postexposure prophylaxis following HIV exposure. JAMA. 1999 Apr 14; 281(14):1269-70.
        View in: PubMed
      69. Kahn JG, Brindis CD, Glei DA. Pregnancies averted among U.S. teenagers by the use of contraceptives. Fam Plann Perspect. 1999 Jan-Feb; 31(1):29-34.
        View in: PubMed
      70. Marseille E, Kahn JG, Saba J. Cost-effectiveness of antiviral drug therapy to reduce mother-to-child HIV transmission in sub-Saharan Africa. AIDS. 1998 May 28; 12(8):939-48.
        View in: PubMed
      71. Kahn JG, Gurvey J, Pollack LM, Binson D, Catania JA. How many HIV infections cross the bisexual bridge? An estimate from the United States. AIDS. 1997 Jul; 11(8):1031-7.
        View in: PubMed
      72. Marx R, Franks PE, Kahn JG, Sanstad KC, Werdegar D. HIV education and prevention in California: problems and progress. HIV Education and Prevention Evaluation Team. AIDS Public Policy J. 1997; 12(1):31-45.
        View in: PubMed
      73. Kahn JG, Sanstad KC. The role of cost-effectiveness analysis in assessing HIV-prevention interventions. AIDS Public Policy J. 1997; 12(1):21-30.
        View in: PubMed
      74. Kahn JG. The cost-effectiveness of HIV prevention targeting: how much more bang for the buck? Am J Public Health. 1996 Dec; 86(12):1709-12.
        View in: PubMed
      75. Grover CM, Kuppermann M, Kahn JG, Washington AE. Concurrent hysterectomy at bilateral salpingo-oophorectomy: benefits, risks, and costs. Obstet Gynecol. 1996 Dec; 88(6):907-13.
        View in: PubMed
      76. McFarland W, Kahn JG, Katzenstein DA, Mvere D, Shamu R. Deferral of blood donors with risk factors for HIV infection saves lives and money in Zimbabwe. J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Jun 1; 9(2):183-92.
        View in: PubMed
      77. Kahn JG, Luft H, Smith MD. HIV risk adjustment: issues and proposed approaches. J Acquir Immune Defic Syndr Hum Retrovirol. 1995; 8 Suppl 1:S53-66.
        View in: PubMed
      78. Kahn JG, Mokdad AH, Deming MS, Roungou JB, Boby AM, Excler JL, Waldman RJ. Avoiding missed opportunities for immunization in the Central African Republic: potential impact on vaccination coverage. Bull World Health Organ. 1995; 73(1):47-55.
        View in: PubMed
      79. Lurie P, Avins AL, Phillips KA, Kahn JG, Lowe RA, Ciccarone D. The cost-effectiveness of voluntary counseling and testing of hospital inpatients for HIV infection. JAMA. 1994 Dec 21; 272(23):1832-8.
        View in: PubMed
      80. Phillips KA, Lowe RA, Kahn JG, Lurie P, Avins AL, Ciccarone D. The cost-effectiveness of HIV testing of physicians and dentists in the United States. JAMA. 1994 Mar 16; 271(11):851-8.
        View in: PubMed
      81. Walker CK, Kahn JG, Washington AE, Peterson HB, Sweet RL. Pelvic inflammatory disease: metaanalysis of antimicrobial regimen efficacy. J Infect Dis. 1993 Oct; 168(4):969-78.
        View in: PubMed
      82. Lurie P, Lowe RA, Avins AL, Phillips KA, Kahn JG, Franks PE, Ciccarone DH. Undiagnosed HIV infection in acute care hospitals. N Engl J Med. 1992 Dec 17; 327(25):1815-6.
        View in: PubMed
      83. Kahn JG, Lurie P, Grumbach K. Consumer choices and the American health care system. JAMA. 1992 Sep 9; 268(10):1265-6.
        View in: PubMed
      84. Lurie P, Kahn JG, Wolfe SM. Regulation of benzodiazepine prescription. JAMA. 1992 Jul 22-29; 268(4):472-3; author reply 473-4.
        View in: PubMed
      85. Kahn JG, Walker CK, Washington AE, Landers DV, Sweet RL. Diagnosing pelvic inflammatory disease. A comprehensive analysis and considerations for developing a new model. JAMA. 1991 Nov 13; 266(18):2594-604.
        View in: PubMed
      86. Peterson HB, Walker CK, Kahn JG, Washington AE, Eschenbach DA, Faro S. Pelvic inflammatory disease. Key treatment issues and options. JAMA. 1991 Nov 13; 266(18):2605-11.
        View in: PubMed
      87. Marx R, Aral SO, Rolfs RT, Sterk CE, Kahn JG. Crack, sex, and STD. Sex Transm Dis. 1991 Apr-Jun; 18(2):92-101.
        View in: PubMed
      James's Networks
      Click the "See All" links for more information and interactive visualizations!
      Related Concepts
      Derived automatically from this person's publications.
      See all (332) concept(s)
      _
      Co-Authors
      People in Profiles who have published with this person.
      See all (19) people
      _
      Related Authors
      People who share similar concepts with this person.
      See all (60) people
      _
      Same Department
      Search Department
      Back to TOP